Discovery a series of novel inhibitors of human dihydroorotate dehydrogenase: Biological activity evaluation and molecular docking
出版年份 2023 全文链接
标题
Discovery a series of novel inhibitors of human dihydroorotate dehydrogenase: Biological activity evaluation and molecular docking
作者
关键词
-
出版物
Chemical Biology & Drug Design
Volume -, Issue -, Pages -
出版商
Wiley
发表日期
2023-11-06
DOI
10.1111/cbdd.14388
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Depletion of SOD2 enhances nasopharyngeal carcinoma cell radiosensitivity via ferroptosis induction modulated by DHODH inhibition
- (2023) Alvan Amos et al. BMC CANCER
- Teriflunomide Concentrations in Cerebrospinal Fluid and Plasma in Patients with Multiple Sclerosis: A Pharmacokinetic Study
- (2023) Jan Lycke et al. CNS DRUGS
- Tiratricol, a thyroid hormone metabolite, has potent inhibitory activity against human dihydroorotate dehydrogenase
- (2023) Shuying Cao et al. Chemical Biology & Drug Design
- A patent review of human dihydroorotate dehydrogenase (hDHODH) inhibitors as anticancer agents and their other therapeutic applications (1999-2022)
- (2023) Vivek K. Vyas et al. Recent Patents on Anti-Cancer Drug Discovery
- Uridine Inhibits Hepatocellular Carcinoma Cell Development by Inducing Ferroptosis
- (2023) Liuliu Zi et al. Journal of Clinical Medicine
- Teriflunomide modulates both innate and adaptive immune capacities in multiple sclerosis
- (2023) Qi Wu et al. Multiple Sclerosis and Related Disorders
- Recent advances of human dihydroorotate dehydrogenase inhibitors for cancer therapy: Current development and future perspectives
- (2022) Lele Zhang et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Identification of Human Dihydroorotate Dehydrogenase Inhibitor by a Pharmacophore-Based Virtual Screening Study
- (2022) Salvatore Galati et al. MOLECULES
- A first in man study to evaluate the safety, pharmacokinetics and pharmacodynamics of RP7214, a dihydroorotate dehydrogenase inhibitor in healthy subjects
- (2022) Ajit Nair et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Upregulation of cytidine deaminase in NAT1 knockout breast cancer cells
- (2022) Kyung U. Hong et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Targeting lipid metabolism for ferroptotic cancer therapy
- (2022) Minhua Luo et al. APOPTOSIS
- Synthesis and biological evaluation of new quinoline‐4‐carboxylic acid‐chalcone hybrids as dihydroorotate dehydrogenase inhibitors
- (2022) Milena M. Petrović et al. ARCHIV DER PHARMAZIE
- Cancer-selective metabolic vulnerabilities in MYC-amplified medulloblastoma
- (2022) William D. Gwynne et al. CANCER CELL
- Discovery of potent human dihydroorotate dehydrogenase inhibitors based on a benzophenone scaffold
- (2022) Chungen Li et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of potential natural dihydroorotate dehydrogenase inhibitors and their synergism with brequinar via integrated molecular docking, dynamic simulations and in vitro approach
- (2022) Asmaa Khairy et al. Scientific Reports
- DHODH and cancer: promising prospects to be explored
- (2021) Yue Zhou et al. Cancer & Metabolism
- Design, Synthesis, and Biological Evaluation of a Novel Series of Teriflunomide Derivatives as Potent Human Dihydroorotate Dehydrogenase Inhibitors for Malignancy Treatment
- (2021) Chungen Li et al. JOURNAL OF MEDICINAL CHEMISTRY
- Teriflunomide: Pediatric First Approval
- (2021) Julia Paik PEDIATRIC DRUGS
- Optimization of Tetrahydroindazoles as Inhibitors of Human Dihydroorotate Dehydrogenase and Evaluation of Their Activity and In Vitro Metabolic Stability
- (2020) Gergana Popova et al. JOURNAL OF MEDICINAL CHEMISTRY
- Re-evaluation of Brequinar sodium, a dihydroorotate dehydrogenase inhibitor
- (2019) Godefridus J. Peters NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS
- Use of human Dihydroorotate Dehydrogenase (hDHODH) Inhibitors in Autoimmune Diseases and New Perspectives in Cancer Therapy
- (2018) Marco L. Lolli et al. Recent Patents on Anti-Cancer Drug Discovery
- Revisiting the role of dihydroorotate dehydrogenase as a therapeutic target for cancer
- (2018) Joseph T. Madak et al. PHARMACOLOGY & THERAPEUTICS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More